In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Nektar Therapeutics (NASDAQ: NKTR) was $29.12 for the day, up 19.10% from the previous closing price of $24.45. In other words, the price has increased by $19.10 from its previous closing price. On the day, 25.99 million shares were traded.
Ratios:
Our analysis of NKTR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.24 and its Current Ratio is at 3.24. In the meantime, Its Debt-to-Equity ratio is 13.59 whereas as Long-Term Debt/Eq ratio is at 12.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on June 24, 2025, Reiterated its Buy rating but revised its target price to $120 from $6.50 previously.
On June 24, 2025, BTIG Research reiterated its Buy rating and also lowered its target price recommendation from $60 to $100.
Jefferies Upgraded its Hold to Buy on April 11, 2025, while the target price for the stock was maintained at $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 19 ’25 when Zalevsky Jonathan sold 10,712 shares for $0.67 per share. The transaction valued at 7,177 led to the insider holds 305,892 shares of the business.
Wilson Mark Andrew sold 9,996 shares of NKTR for $6,697 on May 19 ’25. The Chief Legal Officer now owns 314,296 shares after completing the transaction at $0.67 per share. On May 19 ’25, another insider, ROBIN HOWARD W, who serves as the President & CEO of the company, sold 23,208 shares for $0.67 each. As a result, the insider received 15,549 and left with 1,063,693 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.14 while its Price-to-Book (P/B) ratio in mrq is 26.30.
Stock Price History:
Over the past 52 weeks, NKTR has reached a high of $27.68, while it has fallen to a 52-week low of $6.48. The 50-Day Moving Average of the stock is 170.17%, while the 200-Day Moving Average is calculated to be 105.00%.
Shares Statistics:
A total of 12.41M shares are outstanding, with a floating share count of 11.96M.
